1. Home
  2. RGNX vs NTGR Comparison

RGNX vs NTGR Comparison

Compare RGNX & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NTGR
  • Stock Information
  • Founded
  • RGNX 2008
  • NTGR 1996
  • Country
  • RGNX United States
  • NTGR United States
  • Employees
  • RGNX N/A
  • NTGR 655
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NTGR Telecommunications Equipment
  • Sector
  • RGNX Health Care
  • NTGR Utilities
  • Exchange
  • RGNX Nasdaq
  • NTGR Nasdaq
  • Market Cap
  • RGNX 661.2M
  • NTGR 709.8M
  • IPO Year
  • RGNX 2015
  • NTGR N/A
  • Fundamental
  • Price
  • RGNX $11.86
  • NTGR $25.04
  • Analyst Decision
  • RGNX Strong Buy
  • NTGR Strong Buy
  • Analyst Count
  • RGNX 7
  • NTGR 3
  • Target Price
  • RGNX $30.29
  • NTGR $39.00
  • AVG Volume (30 Days)
  • RGNX 537.9K
  • NTGR 531.6K
  • Earning Date
  • RGNX 11-06-2025
  • NTGR 10-29-2025
  • Dividend Yield
  • RGNX N/A
  • NTGR N/A
  • EPS Growth
  • RGNX N/A
  • NTGR N/A
  • EPS
  • RGNX N/A
  • NTGR N/A
  • Revenue
  • RGNX $161,318,000.00
  • NTGR $699,572,000.00
  • Revenue This Year
  • RGNX $198.02
  • NTGR $5.13
  • Revenue Next Year
  • RGNX $2.67
  • NTGR $2.74
  • P/E Ratio
  • RGNX N/A
  • NTGR N/A
  • Revenue Growth
  • RGNX 91.30
  • NTGR 2.88
  • 52 Week Low
  • RGNX $5.04
  • NTGR $18.75
  • 52 Week High
  • RGNX $13.93
  • NTGR $36.86
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 53.04
  • NTGR 29.45
  • Support Level
  • RGNX $10.70
  • NTGR $28.81
  • Resistance Level
  • RGNX $12.05
  • NTGR $25.99
  • Average True Range (ATR)
  • RGNX 0.73
  • NTGR 1.28
  • MACD
  • RGNX -0.10
  • NTGR -0.62
  • Stochastic Oscillator
  • RGNX 79.32
  • NTGR 11.88

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

Share on Social Networks: